Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-05-08T13:54:54.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-05-01T06:23:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-24T01:18:32.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about various types of recurrent and refractory lymphomas, as well as details about a clinical trial involving pembrolizumab and its identifiers. The previous content regarding the trial's objectives and treatment protocols has been significantly reduced.
    Difference
    52%
    Check dated 2025-04-16T20:37:25.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T15:00:13.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.6%
    Check dated 2025-04-02T00:24:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.